Error
  • The template for this display is not available. Please contact a Site administrator.
Warning
  • Assign the component VirtueMart to a menu item

Rimonabant

User Rating: 4 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive
Rimonabant
Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. In Europe, it is indicated for use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m2, or patients wih a BMI greater than 27 kg/m2 with associated risk factors, such as type 2 diabetes or...

Read more ...

Xenical Diet Pills

User Rating: 4 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive
Xenical
Xenical is a prescription drug manufactured by the Roche pharmaceutical company, which is intended for use to help obese patients to lose weight. It is generally prescribed when individuals over a certain level on the body mass index (BMI) have found that other natural diet plans have not been successful and added assistance is required in order to attain a...

Read more ...

Meridia Diet Pills

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive
Meridia
  Meridia is a prescription weight loss drug in a brand name form of the generic diet drug called sibutramine. This pill is formulated to help people who suffer from obesity to take control of their efforts to lose weight through the assistance of appetite suppression. It is a medication that is taken in conjunction with a nutritious diet that...

Read more ...

Ionamin Diet Pills

User Rating: 4 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive
Ionamin
Ionamin is a prescription diet drug that is made up of the popular weight loss ingredient called Phentermine. This is the most popularly prescribed form of medication to assist obese individuals with their efforts to reduce their weight in order to decrease their risk of certain serious health problems such as high blood pressure, high cholesterol, and diabetes. As the...

Read more ...